BC
SLDB icon

Birchview Capital’s Solid Biosciences SLDB Stock Holding History

Birchview Capital’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.51M Sell
625,980
-79,975
-11% -$514K 2.57% 9
2025
Q4 		$3.98M Buy
705,955
+409,000
+138% +$2.22M 2.33% 12
2025
Q3 		$1.83M Buy
296,955
+118,187
+66% +$691K 1.38% 21
2025
Q2 		$871K Buy
178,768
+50,000
+39% +$177K 0.86% 27
2025
Q1 		$476K Buy
+128,768
New +$551K 0.41% 34
2018
Q4 		– Sell
-400
Closed -$283K – 55
2018
Q3 		$283K Hold
400
– – 0.18% 45
2018
Q2 		$214K Sell
400
-933
-70% -$287K 0.15% 44
2018
Q1 		$150K Buy
+1,333
New +$450K 0.1% 46

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return